At a glance
- Originator GlaxoSmithKline
- Class Anthelmintics; Benzimidazoles; Small molecules
- Mechanism of Action RNA polymerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helminthiasis
Most Recent Events
- 31 Dec 2003 Discontinued - Phase-III for Helminthiasis in Europe (unspecified route)
- 25 Oct 2002 Phase-III clinical trials in Helminthiasis in Europe (unspecified route)